Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.
Reviewers:
(1) Mohamed M. M. Elnasharty, National Research Centre, Egypt.
(2) Sonal Rastogi, Tata Medical Center, India.
Additional Reviewers:
(1) Dilek Kitapcioglu, Acibadem Mehmet Ali Aydinlar University, Turkey.
(2) Aman Shrivastava, G.L.A University, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Mohamed M. M. Elnasharty, Egypt) | File 1 | NA
Stage 2 | Peer review report_2 (Sonal Rastogi, India) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA